CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

433 hedge funds and large institutions have $3.28B invested in CRISPR Therapeutics in 2022 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 124 increasing their positions, 122 reducing their positions, and 62 closing their positions.

Holders
433
Holders Change
-11
Holders Change %
-2.48%
% of All Funds
7.32%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
59
Increased
124
Reduced
122
Closed
62
Calls
$193M
Puts
$182M
Net Calls
+$10.4M
Net Calls Change
+$17.4M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$183M
2
State Street
2
State Street
Massachusetts
$95.4M
3
Capital International Investors
3
Capital International Investors
California
$283M
4
Bank of America
4
Bank of America
North Carolina
$74.5M
5
PAMS
5
Pictet Asset Management (Switzerland)
Switzerland
$25.7M

Top Sellers

1
Allspring Global Investments
1
Allspring Global Investments
North Carolina
$16.6M
2
Two Sigma Investments
2
Two Sigma Investments
New York
$2.76M
3
Voloridge Investment Management
3
Voloridge Investment Management
Florida
$9M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$2.24M
5
Citadel Advisors
5
Citadel Advisors
Florida
$499K
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$565M 9,727,531 +323,460 +3%
Capital International Investors
2
Capital International Investors
California
$283M 4,663,954 +1,061,802 +29%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$279M 4,584,098 -35,649 -0.8%
NAMA
4
Nikko Asset Management Americas
New York
$276M 4,584,098 -35,649 -0.8%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$183M 3,014,551 +1,848,437 +159%
BlackRock
6
BlackRock
New York
$131M 2,152,126 -126,648 -6%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$98.4M 1,619,022 +357,400 +28%
NMC
8
NEA Management Company
Maryland
$96.6M 1,590,002 – –
State Street
9
State Street
Massachusetts
$95.4M 1,569,860 +1,092,384 +229%
Loomis, Sayles & Company
10
Loomis, Sayles & Company
Massachusetts
$84.9M 1,396,258 +105,353 +8%
Vanguard Group
11
Vanguard Group
Pennsylvania
$80.4M 1,323,141 +105,852 +9%
Bank of America
12
Bank of America
North Carolina
$74.5M 1,226,712 +500,763 +69%
CS
13
Credit Suisse
Switzerland
$56.1M 923,671 -94,156 -9%
BG
14
Bellevue Group
Switzerland
$56M 922,005 -4,900 -0.5%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$43.4M 714,195 +51,106 +8%
JPMorgan Chase & Co
16
JPMorgan Chase & Co
New York
$40.3M 663,060 +16,488 +3%
Norges Bank
17
Norges Bank
Norway
$35.9M 590,577 -23,256 -4%
Federated Hermes
18
Federated Hermes
Pennsylvania
$35.3M 580,918 – –
Renaissance Technologies
19
Renaissance Technologies
New York
$34.6M 568,700 -133,600 -19%
Morgan Stanley
20
Morgan Stanley
New York
$34.5M 567,458 +50,070 +10%
VVM
21
Versant Venture Management
California
$30.3M 498,558 – –
Goldman Sachs
22
Goldman Sachs
New York
$30.1M 495,206 +378,609 +325%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$26.7M 439,926 +199,939 +83%
PAMS
24
Pictet Asset Management (Switzerland)
Switzerland
$25.7M 423,287 +419,387 +10,754%
Charles Schwab
25
Charles Schwab
California
$21.2M 348,123 -6,680 -2%
1
2 3 4 5